Sai Parenteral's Limited IPO

Established in 2001, Sai Parenteral's Limited is a diversified pharmaceutical formulations company specializing in the research, development, and manufacturing of a wide array of healthcare products. The company operates through two primary business verticals: Branded Generic Formulations and Contract Development and Manufacturing Organisation (CDMO) services, catering to both domestic and international markets.

Don't have a Navia account? Sign up

The company’s extensive product portfolio covers critical therapeutic areas, including cardiovascular, neuropsychiatry, anti-diabetic, and respiratory health, as well as antibiotics, gastroenterology, and dermatology. Its manufacturing capabilities span multiple dosage forms, such as injectables, tablets, capsules, liquid orals, and ointments, alongside a specialized focus on vitamins, minerals, and supplements (VMS) and analgesics.

How do I apply for the Sai Parenteral's IPO?

You can apply for the Sai Parenteral's IPO using any supported UPI app by following two steps:

• Enter your bid on Navia App
• Accept UPI mandate on your phone

On acceptance of the mandate, the bid amount will get blocked in your bank account.